金固股份（002488.SZ）12月10日在投资者互动平台表示，2025年10~11月，阿凡达车轮销售延续了积极 态势。我们通过产能优化为长期向好奠定基础。 每经AI快讯，有投资者在投资者互动平台提问：阿凡达车轮供不应求，2025又新增了8条产线，十月和 十一月的销售是否持续向好？ （文章来源：每日经济新闻） ...

Core Viewpoint - The company is actively exploring the potential applications of its Avatar niobium microalloy materials in various industries, including aerospace, while currently focusing on the automotive sector for large-scale production [1]. Group 1: Product Development - The Avatar niobium microalloy developed by the company is noted for its high strength, good toughness, low cost, and low carbon emissions, making it suitable for a wide range of applications [1]. - The company has already achieved large-scale production of the Avatar material in the wheel industry [1]. Group 2: Future Plans - In addition to the current applications in the automotive sector, the company is advancing the development of other horizontal applications for the Avatar materials, including components for robotic mechanisms [1].

Group 1 - The 2024-2025 Annual Marketing Conference and the 23rd Outstanding Brand Marketing Annual Meeting will be held in Beijing, focusing on the collision between brand economy and traffic economy, aiming to promote brand competition from "traffic competition" to "value cultivation" [1] - On December 10, a total of 1.41 million shares from 8 companies will be unlocked, with a total market value of 2.388 billion yuan, including significant unlocks from Nanshan Zhishang, Xingtong Co., and Yunding Technology [1] - The unlocked shares include over 10 million shares from three companies, with Nanshan Zhishang leading at 71.4286 million shares, followed by Xingtong Co. at 41.4916 million shares, and Yunding Technology at 10.0526 million shares [1] Group 2 - Nine companies disclosed stock repurchase progress on December 10, with five companies announcing new repurchase plans, one plan approved by shareholders, and three plans completed [2] - Among the new repurchase plans, four companies announced amounts exceeding 10 million yuan, with Huitai Medical, Songcheng Performance, and Jinggu Co. having the highest proposed repurchase amounts of 250 million yuan, 200 million yuan, and 60 million yuan respectively [2] - Huadong Medicine has the highest repurchase amount approved by shareholders, proposing to repurchase up to 6.494 million yuan [2]

Group 1 - Rhein Biotech and Jia Mei Packaging's controlling shareholders are planning changes in company control, with trading suspension starting from December 10, 2025, for Rhein Biotech expected to last no more than 10 trading days and for Jia Mei Packaging no more than 2 trading days [1][2] - Rhein Biotech intends to acquire at least 80% of Beijing Jinkangpu Food Technology Co., Ltd. through a combination of issuing shares and cash payment, which will make Beijing Jinkangpu a subsidiary included in the consolidated financial statements [1] - Jia Mei Packaging's controlling shareholder is also in discussions regarding a potential change in control, with specific transaction details still under negotiation [2] Group 2 - Haiguang Information has terminated its plan to merge with Zhongke Shuguang through a share exchange, as approved in a board meeting on December 9, 2025 [3] - Huatai Medical plans to repurchase shares with a total amount not less than RMB 200 million and not exceeding RMB 250 million, with a repurchase price cap of RMB 315 per share [4] - Songcheng Performing Arts and Jingu Co., Ltd. also announced share repurchase plans, with Songcheng aiming for a total of RMB 100 million to RMB 200 million and Jingu targeting RMB 30 million to RMB 60 million [4] Group 3 - Xiamen Airport is planning to acquire 100% of the shares of Zhaoxiang Technology, a wholly-owned subsidiary of its controlling shareholder, Xiamen Xiangye Group [5] - Borui Communication intends to acquire 51% of Meijing Technology from related parties for a total price of RMB 66.49 million [6] - Gu Ao Technology's actual controller is planning a change in control, with trading suspension starting from December 8, 2025, and expected to last no more than 3 trading days [6] Group 4 - ST Kevin's application to revoke the risk warning on its stock has been approved, with trading suspension for one day on December 10, 2025, and resuming trading on December 11, 2025 [6] - Huailun Crystal's stock will be suspended for one day starting December 10, 2025, due to false disclosures in its annual reports for 2021 and 2022 [7] - The stock of Jia Ao Environmental Protection will also be suspended for one day on December 10, 2025, due to an administrative penalty notice received from the regulatory authority [12] Group 5 - The company Yongmota plans to invest approximately RMB 400 million in a new project for magnesium-aluminum alloy components for the automotive and robotics industries [20] - ST Ningke is executing a capital reserve transfer plan to increase its share capital, with a total share increase from 684.88 million to 1.62 billion shares [21] - Yingpais plans to increase its shareholding through a combination of bank loans and self-funding, with a total investment of no less than RMB 60 million and no more than RMB 120 million [22]

Summary of Key Points Core Viewpoint - On December 9, several A-share listed companies disclosed their shareholding changes, with notable increases in shareholdings from companies like Financial Street, Songcheng Performance, and others, while 14 companies, including Shengyi Technology and Shen Zhou Information, reported reductions in shareholdings [1][2][3] Group 1: Shareholding Increases - Financial Street reported that Harmony Health Insurance increased its shareholding by 7.0384 million shares from December 4 to December 8 [2][3] - Songcheng Performance plans to repurchase shares worth between 100 million to 200 million yuan for cancellation and reduction of registered capital [2][3] - Yingpais intends to increase its shareholding by 60 million to 120 million yuan [2][3] - Huatai Medical plans to repurchase shares worth between 200 million to 250 million yuan [2][3] - American Shares plans to repurchase shares worth between 30 million to 60 million yuan [2][3] Group 2: Shareholding Reductions - Shengyi Technology's largest shareholder, Guangxin Group, reduced its holdings by 12.91 million shares from November 26 to December 9 [2][3] - Saiwei Microelectronics' shareholder, Shanghai Lingguan, plans to reduce holdings by no more than 14,500 shares [2][3] - Shen Zhou Information's controlling shareholder, Shenma Software, plans to reduce its holdings by no more than 2.95% [2][3] - Demingli's shareholder, Wei Hongzhang, reduced holdings by a total of 2.8433 million shares from November 7 to December 8 [2][3] - Ying Shisheng's controlling shareholder, Tang Qiu, reduced holdings by 1% [2][3] - Meixin Technology's shareholder, Runke Investment, plans to reduce holdings by no more than 1.6047% [2][3] - Benli Technology's deputy general manager, Sheng Mengjun, plans to reduce holdings by no more than 0.07% [2][3] - Donghua Testing's controlling shareholder and its concerted actions plan to reduce holdings by no more than 1.99% [2][3] - Kute Intelligent's controlling shareholder's concerted action, Zhang Yunlan, plans to reduce holdings by no more than 2% [2][3] - Haomei New Materials' shareholder, Chi Yao Investment, plans to reduce holdings by no more than 0.44% [2][3] - Aokang International's shareholder, Xiang Jinyu, plans to reduce holdings by no more than 3% [2][3] - Aerospace Development's fourth largest shareholder, Aerospace Science and Industry Asset Company, reduced holdings by 1.3435 million shares on December 9 [2][3] - Lide New Energy's shareholder, Shandong Electric Construction, plans to reduce holdings by no more than 1% [2][3] - Yingfang Micro's shareholding by Dongfang Securities has fallen below 5% [2][3]

Group 1 - Wanma Technology has been pre-awarded a total of 59.9434 million yuan for multiple State Grid projects, which accounts for 14.49% of its latest audited main business revenue [1] - Tianen Kang's subsidiary received a drug registration certificate for Methimazole tablets, a medication used for hyperthyroidism [2] - Taijing Technology invested 10 million yuan to establish a special fund focused on high-speed network communication chips [3] Group 2 - Youyou Foods plans to use 10 million yuan of its own funds to purchase principal-protected financial products with an expected annual yield of 0.5%-5.0% [4] - Yangfan New Materials announced the release of detention measures against its controlling shareholder, allowing him to resume his duties [5] - Xianju Pharmaceutical received approval for a supplementary application for Nicardipine injection, a calcium channel blocker used for acute hypertension [6] Group 3 - Jingu Co. plans to repurchase shares worth 30-60 million yuan for employee stock ownership plans or equity incentives [7] - Double Tower Foods' Thai subsidiary has completed the construction of its production line and is in the initial production phase [8] - Tongyi Zhong intends to invest approximately 198 million yuan in a project for the industrialization of ultra-high molecular weight polyethylene fibers [9][10] Group 4 - Zhangyue Technology received a dividend of 4.99 million yuan from its stake in Dianzhong Technology, which represents 10.12% of its audited net profit for 2024 [11] - Sihua Electronics announced the resignation of its general manager due to job transfer, with the current manager continuing until a new one is appointed [12] - Jiutian Pharmaceutical's new drug JMHT06 has received approval for clinical trials for acute gouty arthritis [13] Group 5 - Anlian Ruishi has established a joint venture for embodied intelligent robots with a registered capital of 20 million yuan [14] - Kelin Electric's application for a private placement has been accepted by the Shanghai Stock Exchange [15] - Guoyao Modern's subsidiary has received approval for the listing of Agomelatine raw materials, used in antidepressant synthesis [16] Group 6 - Xintiandi's application for the listing of Ferrous Fumarate raw materials has been approved, which is used for treating iron deficiency anemia [17] - ST Weihai, as the leading party, won a bid for a smart agriculture project worth 652 million yuan, accounting for 26.27% of its 2024 audited revenue [18] - Tian Youwei plans to purchase 100% of Krämer Automotive Systems for 1 million euros [19] Group 7 - Guangdong Yuedian A's subsidiary has successfully put into operation the third unit of its Dapu Power Plant project [20] - China Life's total premium exceeded 700 billion yuan as of November 30, 2025 [21] - Shoukai Co. achieved a total signed amount of 15.988 billion yuan in the first 11 months of 2025 [22] Group 8 - Kehua Bio's subsidiary has obtained a medical device registration certificate for an automatic chemiluminescence immunoassay analyzer [23] - Chengyi Pharmaceutical received a drug registration certificate for Torasemide tablets, which have passed the consistency evaluation [24] - Chongqing Construction won a bid for a municipal engineering project worth approximately 1.714 billion yuan [25] Group 9 - Hanjian Heshan signed a procurement contract for pipes worth 388 million yuan [26] - Jiuzhou Pharmaceutical plans to use up to 1 billion yuan of idle raised funds for cash management [27] - Xinwufeng reported an 80.97% year-on-year increase in pig sales in November 2025 [28] Group 10 - Luoniushan reported a 13.57% year-on-year increase in pig sales revenue in November 2025 [29] - Fushilai received a drug registration certificate for Alpha-Lipoic Acid tablets, used for diabetic neuropathy [30] - Dizhe Pharmaceutical presented research data on two innovative drugs at the 67th American Society of Hematology conference [31] - David Medical's subsidiary received two medical device registration certificates for single-use gastric tubes and electronic ureteral endoscope catheters [32]

Group 1 - The company, Jingu Co., Ltd. (002488.SZ), announced a share repurchase plan aimed at implementing an employee stock ownership plan or equity incentive [1] - The total amount of funds for the share repurchase will not be less than RMB 30 million (inclusive) and will not exceed RMB 60 million (inclusive), with the actual amount determined at the end of the repurchase period [1] - The maximum repurchase price per share is set at RMB 13.63 (inclusive) [1]

智通财经APP讯，金固股份(002488.SZ)公告，公司拟回购公司股份用于实施员工持股计划或股权激励。 回购股份的价格不超过13.63元/股(含);回购股份的资金总额不低于3000万元(含)且不超过6000万元(含)。 拟回购股份的实施期限自董事会审议通过本次回购股份方案之日起12个月内。 ...

（3）拟回购股份的价格上限：本次回购股份的价格不超过人民币13.63元/ 股（含）； （4）拟用于回购股份的资金总额：本次回购股份的资金总额不低于人民币 3,000万元（含）且不超过人民币6,000万元（含），具体回购股份资金总额以回 购期满时实际回购使用的资金总额为准； 证券代码：002488 证券简称：金固股份 编号：2025-056 浙江金固股份有限公司 关于回购公司股份方案的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 重要内容提示： 1、回购方案的主要内容 （1）拟回购股份的种类：公司发行上市的人民币普通股（A股）股票； （2）拟回购股份的用途：用于实施员工持股计划或股权激励。 （5）拟回购股份的数量、占公司总股本的比例：按本次回购股份价格上限 人民币13.63元/股测算，本次回购股份数量下限至上限为：2,201,028股至 4,402,054股，占公司目前总股本比例下限至上限为：0.22%至0.44%（四舍五入 测算的数据，下同），具体回购股份的数量以回购期满时实际回购的股份数量为 准； （4）本次回购股份的资金来源于自有资金及自筹资金，可 ...

一、审议通过了《关于回购公司股份方案的议案》。 具体内容详见于《证券时报》《中国证券报》及公司指定信息披露网站"巨 潮资讯网"http://www.cninfo.com.cn上披露的《关于回购公司股份方案的公 告》。 表决结果：同意9票；反对0票；弃权0票，表决通过。 证券代码：002488 证券简称：金固股份 编号：2025-055 浙江金固股份有限公司 第六届董事会第十五次会议决议的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 浙江金固股份有限公司（以下简称"公司"）第六届董事会第十五次会议（以 下简称"会议"）通知于2025年12月5日以专人送达、电子邮件、传真方式发出， 会议于2025年12月9日在浙江省杭州市富阳区浙江金固股份有限公司三楼会议室 以现场及通讯表决方式召开。应到董事9人，实到董事9人。公司高管人员列席了 本次会议。本次会议的召集、召开以及参与表决董事人数符合《中华人民共和国 公司法》《公司章程》等有关法律、法规的规定。会议由董事长孙锋峰先生主持， 经参加会议董事认真审议并经记名投票方式表决，通过以下决议： 特此公告。 浙江金固股 ...